Ulcerative Colitis Treatment Case: Beyond Clinical Remission to Normalization of Inflammation Levels
Hello. This is HanStep Korean Medicine Clinic, which has been researching and treating ulcerative colitis since 2007. Today, we will look at the proper conclusion process of treatment through the case of a patient in their 40s with ulcerative colitis.
Patient Symptoms and Background
This patient began experiencing mucous stools in July 2023 and was diagnosed with ulcerative colitis after an endoscopy. Having seen no results with Western medicine, the patient tried a combination of pharmacy herbal medicine and treatment at another clinic, but experienced repeated improvements and relapses before visiting our clinic in May 2025.
At the time of the initial visit, the patient had 2–4 bowel movements per day, bloody stools twice a week, and persistent mucous stools. The patient also suffered from indigestion, cold hands and feet, and rhinitis.
The Difference Between Clinical Remission and Actual Inflammation
It is easy to think that once bloody stools and diarrhea disappear, the condition has improved, but this is only 'clinical remission', where symptoms have merely been improved. Even in a state of clinical remission, there is a high risk of recurrence because intestinal inflammation often remains. Therefore, after reaching the first goal of clinical remission, treatment must continue to achieve the second goal: normalization of inflammation levels.
The Importance of Stool Calprotectin Testing
In cases of ulcerative colitis, blood tests (WBC, CRP, ESR, etc.) often show normal ranges. Therefore, the stool calprotectin test is essential to accurately grasp the level of intestinal inflammation. This test is a highly reliable marker that correlates with endoscopic findings by more than 80%.
Treatment Progress and Results
- May 2025: Stool calprotectin 3346 points, fecal occult blood test positive (693 points)
- June 2025: Bowel movements reduced to once a day after one month; bloody stools disappeared; digestive symptoms improved
- August 2025: Stool calprotectin normalized to 8.9 points
- October–December 2025: Prescription adjustment and detailed treatment conducted to resolve mucous stools and rhinitis issues
- January–February 2026: Stool calprotectin maintained at a complete normal level of less than 3.8; mucous stools disappeared and digestion is good
Symptoms improved quickly in the beginning, and in the latter part of the treatment, we were able to completely resolve the issue by carefully targeting the remaining mucous stools and micro-inflammation. We now plan to conclude the treatment after endoscopic confirmation.
Concluding the Treatment
For ulcerative colitis, it is important not only to improve clinical symptoms but also to bring stool inflammation levels back to completely normal ranges. A thorough conclusion is the key to preventing recurrence.
Clinic Information
- Clinic Name: HanStep Korean Medicine Clinic (Representative: Lee Byung-hee)
- Address: Suite 307, JB Miso Building, 841 Nonhyeon-ro, Gangnam-gu, Seoul
- Inquiry: Available through our website (hanstep.co.kr).
- You can also check various treatment cases on our official YouTube channel.
- To protect patient rights, this clinic strictly complies with the Privacy Policy and relevant Terms and Conditions.